EUVIMEDEUVIMED entdecken
Systematische Übersicht

Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review

Maria Elizabeth Ferreira MD, Maurício De Melo Mattos MD, Cristina Guimarães Pondè MD

IOSR Journal of Dental and Medical Sciences · 2026-03 · 25 (3) · 67-75

DOI: 10.9790/0853-2503026775 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-03. Verfasst von Maria Elizabeth Ferreira MD und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To synthesize current evidence on the association between obesity and cardiovascular diseases (CVD), covering pathophysiology, clinical implications, and modern management strategies. Methodology: A systematic review of scientific literature conducted across platforms such as PubMed, Cochrane, and international society guidelines (ESC, ACC, SBC), including studies in English, Spanish, and Portuguese.

Results

Obesity is a multifactorial chronic disease acting through a neuro-hormonal-inflammatory axis. Visceral and epicardial adipose tissue function as active endocrine organs, secreting pro-inflammatory cytokines (IL-6, TNFα) that promote atherogenesis and cardiac remodeling. Clinical Manifestations: Obesity is causally linked to heart failure (specifically HFpEF), atrial fibrillation, coronary artery disease, and premature cardiovascular aging. Diagnosis: Body Mass Index (BMI) alone is insufficient for risk stratification. The inclusion of anthropometric criteria, such as waist circumference and the assessment of intermuscular adipose tissue (IMAT), is recommended. Management: Beyond lifestyle interventions, a new pharmacological era (GLP-1 and GIP agonists) has demonstrated a direct reduction in major adverse cardiovascular events (MACE), as evidenced by the SELECT and SUMMIT trials. Bariatric surgery remains the most effective option for sustained weight loss in severe cases.

Conclusion

Obesity must transition from being viewed merely as a comorbidity to being treated as a direct and modifiable therapeutic target in cardiological practice. A proactive and multidisciplinary management approach is essential to mitigate the global burden of cardiovascular disease.

Zitieren

APA

MD, M. E. F., MD, M. D. M. M., & MD, C. G. P. (2026). Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review. IOSR Journal of Dental and Medical Sciences, 25(3), 67-75. https://doi.org/10.9790/0853-2503026775

Vancouver

MD MEF, MD MDMM, MD CGP. Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review. IOSR Journal of Dental and Medical Sciences. 2026;25(3):67-75. doi:10.9790/0853-2503026775

BibTeX
@article{MD2026,
  author = {MD, Maria Elizabeth Ferreira and MD, Maurício De Melo Mattos and MD, Cristina Guimarães Pondè},
  title = {Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review},
  journal = {IOSR Journal of Dental and Medical Sciences},
  year = {2026},
  volume = {25},
  number = {3},
  pages = {67--75},
  doi = {10.9790/0853-2503026775}
}
Kostenlos starten →